Global biopharma access Sepragen supplies state-of-the-art equipment used in manufacturing life-saving biologics and vaccines with existing customers across four continents, presenting a scalable opportunity to upsell expanded systems, service contracts, and upgrade pathways for larger facilities and new production lines.

Rapid scale capabilities Highlight Sepragen’s ability to enable rapid scale-up from lab to production in small footprints with reduced capex and time-to-market, offering a compelling value proposition for contract manufacturers and emerging biotechs expanding capacity or moving from pilot to commercial runs.

Integrated systems edge Leverage the growing portfolio of single-use, continuous chromatography, buffer making, and integrated chromatography-buffers systems to target facilities seeking compact, end-to-end solutions that minimize footprint and capital spend while accelerating deployment of new drugs and vaccines.

Strategic partnerships capitalize on the Shimadzu partnership as a proof point of market validation and potential co-selling or collaboration opportunities with large instrument and process suppliers to access broader customer networks and joint go-to-market programs.

Compliance and support Position Sepragen’s quality, compliance, and exceptional post-sale support as a differentiator for regulated biopharma customers seeking reliable equipment suppliers with strong service ecosystems, opening doors for long-term maintenance deals and spare-parts programs.